Sincalide: Clinical Trials

5 trials of Sincalide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 2 Not applicable, 1 Phase 1, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 11Completed 1
Phase 31Completed 1
Phase 41Completed 1

Follow Sincalide: new trials by email Literature Review of Sincalide trials Research Report on Sincalide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986278 in Healthy Male Participants
[14C] BMS-986278, KinevacĀ® - Healthy Volunteers
Phase 1CompletedBristol-Myers Squibb92020-10-152022-06-02
A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects
Albiglutide 50 mg, Placebo, CCK (Kinevac) - Diabetes Mellitus, Type 2
Phase 4CompletedGlaxoSmithKline202015-06-112018-04-05
The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion
Acetaminophen, Metformin, Colesevelam - To Assess the Impact of Bile Acids on Human Glukagon-like-peptide-1 Secretion
Not applicableCompletedFilip Krag Knop102012-07-012015-07-14
Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)
Sincalide, Ursodiol, Fat Meal - Healthy Volunteers
Phase 3CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)312008-06-232020-07-22
Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis
sincalide - Cholestasis
Not applicableCompletedUniversity of Michigan2521997-09-012015-03-25

Conditions studied

Cholestasis (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Gastrointestinal Diseases (1)  ·  Rare Diseases (1)

Sponsors

Bristol-Myers Squibb (1)  ·  Filip Krag Knop (1)  ·  GlaxoSmithKline (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  University of Michigan (1)

Countries

United States (4)  ·  Denmark (1)

Top investigators

Daniel Hillel Teitelbaum (1)  ·  Kong Y Chen, Ph.D. (1)  ·  Ulrich Rohde, MD (1)

Results publications

PMID 27003305, PMID 28543352